Cassava Sciences signs license deal with Yale University, shares up

Neuron system disease

koto_feja/E+ via Getty Images

  • Cassava Sciences (NASDAQ:SAVA) said on Thursday that it has signed a deal with Yale University for a license to intellectual property rights.
  • Stock of the company up 9%.
  • The deal includes an exclusive license to an issued US method

Leave a Reply

Your email address will not be published. Required fields are marked *